Evidence map›Paper›PMID 33316879›Full record

ArticleMolecules (Basel, Switzerland)2020

Design and Characterisation of Inhibitory Peptides against Bleg1_2478, an Evolutionary Divergent B3 Metallo-β-lactamase.

Gayathri Selvaraju, Thean Chor Leow, Abu Bakar Salleh, Yahaya M Normi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Dual Activity BLEG-1 fromInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gayathri SelvarajuEnzyme and Microbial Technology Research Center, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Thean Chor LeowEnzyme and Microbial Technology Research Center, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.ORCID 0000-0002-0280-7735
Abu Bakar SallehEnzyme and Microbial Technology Research Center, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Yahaya M NormiEnzyme and Microbial Technology Research Center, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.ORCID 0000-0003-0707-7361
Universiti Putra Malaysia · MY

Funding

L'Oréal-Unesco Fellowship for Women in Science grant 6300833Universiti Putra Malaysia Putra (UPM) Postgraduate Initiative GP-IPS/2016/9502100
6 · The paper itself

Abstract

Previously, a hypothetical protein (HP) termed Bleg1_2437 (currently named Bleg1_2478) from

Indexed as

Amino Acid SequenceAmpicillinBacillusBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesChemical PhenomenaDrug DesignEvolution, MolecularHydrophobic and Hydrophilic InteractionsMolecular Docking SimulationOligopeptidesRecombinant ProteinsThermodynamicsAmpicillinBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesOligopeptidesRecombinant Proteinsactive siteB3 subclass metallo-β-lactamaseBleg1_2478dockinginhibitioninhibitory peptide

Identifiers

PMID33316879
PMCPMC7763155
OpenAlexW3113284054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.